Results 1 to 10 of about 12,424 (198)

Cidofovir Activity against Poxvirus Infections

open access: yesViruses, 2010
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside analog approved since 1996 for clinical use in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.
Graciela Andrei, Robert Snoeck
exaly   +3 more sources

Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report [PDF]

open access: yesBMC Neurology, 2010
Background To report the clinical course of PML in an apparently immunocompetent patient treated with cidofovir. Case Presentation A 35-year-old immunocompetent man who developed progressive hemianopsia, aphasia, and limb weakness underwent repeated MRI ...
Mørk Sverre J   +6 more
doaj   +2 more sources

Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat [PDF]

open access: yesEmerging Infectious Diseases
Mpox, a reemerging zoonotic disease since 2022, primarily affects the skin; ocular involvement is rarely reported. We present a case of mpox-caused disciform keratitis treated with a combination of cidofovir and tecovirimat.
Xavier Brousse   +8 more
doaj   +2 more sources

Assessment of three antiviral compounds against Borealpox virus infection in a mouse model [PDF]

open access: yesEmerging Microbes and Infections
Borealpox virus (BRPV) is a zoonotic orthopoxvirus which was first documented in Alaska in 2015. Although most human infections are mild, a recent fatal case in an immunocompromised individual highlights the importance of studying this emerging pathogen.
Jérémie Prévost   +7 more
doaj   +2 more sources

Real World Experience using Cidofovir in BK Polyomavirus Haemorrhagic Cystitis following Stem Cell Transplantation-Are Generics Equally Efficacious? [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: BK Polyomavirus induced Haemorrhagic Cystitis (BKPyV-HC), a well-recognised complication following Haematopoietic Cell Transplantation (HCT), is associated with increased organ dysfunction and mortality.
Sharon Lionel   +7 more
doaj   +1 more source

Monkeypox transmission: time to revisit the medical strategy of public health [PDF]

open access: yesInfectious Diseases and Tropical Medicine, 2023
Viral disease outbreaks pose an unprecedented challenge to public health, particularly in areas with limited access to healthcare and infection control resources. Monkeypox is a rare viral zoonosis associated with the monkeypox virus.
S. Prajapati   +5 more
doaj   +1 more source

Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia. [PDF]

open access: yesPLoS ONE, 2015
The benefits of treatment with antiviral therapy for severe adenovirus (AdV) pneumonia are not well established. We described the clinical characteristics and treatment outcomes of early cidofovir treatment of severe AdV pneumonia in non ...
Se Jin Kim   +4 more
doaj   +1 more source

Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model

open access: yesMolecules, 2021
There is no approved antiviral therapy for adenovirus (HAdV) ocular infections. Astodrimer sodium (SPL7013) is a polyanionic dendrimer with antiviral activity.
Eric G. Romanowski   +4 more
doaj   +1 more source

Assessment of Cidofovir for Treatment of Ocular Bovine Herpesvirus-1 Infection in Cattle Using an Ex-Vivo Model

open access: yesViruses, 2021
Bovine herpesvirus-1 (BoHV-1) infection contributes to keratoconjunctivitis, respiratory disease, and reproductive losses in cattle. The objective of this study was to determine the most appropriate ophthalmic antiviral agent for BoHV-1 inhibition using ...
Christopher R. Alling   +6 more
doaj   +1 more source

Surveillance for feline herpesvirus type 1 mutation and development of resistance in cats treated with antiviral medications

open access: yesFrontiers in Veterinary Science, 2023
Feline herpesvirus type 1 (FHV-1) commonly causes ocular surface disease in cats and is treated with antiviral medications targeting viral DNA polymerase (UL30/42).
Andrew C. Lewin   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy